Ablative carbon dioxide laser effective for rhinophyma

Ablative carbon dioxide laser effective for rhinophyma
Good cosmetic outcomes are possible using fractionated ablative carbon dioxide laser therapy for mild-to-moderate cases of rhinophyma, according to research published online Oct. 5 in Lasers in Surgery and Medicine.

(HealthDay)—Good cosmetic outcomes are possible using fractionated ablative carbon dioxide laser therapy for mild-to-moderate cases of rhinophyma, according to research published online Oct. 5 in Lasers in Surgery and Medicine.

Kathryn L. Serowka, M.D., of the University of California in Irvine, and colleagues reported treatment of mild-to-moderate rhinophyma in five patients using aggressive parameters with fractionated ablative laser therapy.

The researchers found that all of the patients, who had relatively mild-to-moderate signs of rhinophyma, tolerated the well. Reepithelialization and self-limited edema and erythema occurred at four to seven days. No adverse events were reported. Patients and physicians observed improved appearance without the typical scarring caused by most other treatments.

"We were able to demonstrate good improvement in texture, color, and size of mild-to-moderate rhinophyma treated with ablative fractionated ," the authors write.

Two authors disclosed financial ties to medical device companies.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Cold-air anesthesia reduces pain of laser treatment

Jun 22, 2012

(HealthDay) -- In ablative fractionated carbon-dioxide (CO2) laser treatment for photoaging, cold-air anesthesia used in conjunction with topical anesthesia reduces pain significantly more than topical an ...

Combo pulsed, non-ablative laser treatment is safe

Aug 20, 2013

(HealthDay)—For facial rejuvenation, a combination treatment of an optimized intense pulsed light source and a non-ablative fractional laser is safe and effective, according to a study published in the ...

Novel approach found for treating hypertrophic scars

Mar 27, 2013

(HealthDay)—Same-session therapy with fractional ablative laser treatment followed immediately with topical application of triamcinolone acetonide suspension is effective in treating patients with hypertrophic ...

Latrepirdine not effective in Huntington's disease

Nov 01, 2012

(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease ...

Recommended for you

Factors ID'd that influence lack of orthopedic follow-up

Oct 18, 2014

(HealthDay)—For patients treated in the emergency department, orthopedic-related and demographic variables influence failure to return for outpatient management ("no-show"), according to a study published ...

Surgery may not fix long-term palsy of spine disease

Oct 17, 2014

(HealthDay)—Duration of palsy should be considered when selecting candidates for surgical management of painless foot drop in patients with degenerative lumbar disorders, according to research published ...

User comments